The new Transform framework is now live and available to access. View the framework page for more information.


Homecare Medicines Services for Immunoglobulin Therapies (Ref: 2020/S 127-312140)


The Homecare Medicines Services for Immunoglobulin Therapies framework agreement, operating on a hub and spoke model with specialist centre prescribing, addresses a market area with an annual spend of approximately £8 million for products and services in the East of England.

Open to member organisations of the East of England NHS Collaborative Procurement Hub, associate members, and other publicly funded bodies, participating organisations are primarily located in the East of England, South East Coast, and Thames Valley and Wessex regions. This framework sustains the aggregated procurement approach in the area of Immunoglobulin Therapies, building on years of experience and expertise.


  • Competitive prices fixed for a two-year period
  • Complaint route for homecare medicines service
  • Robust call-off procedure and innovative Key Performance Indicators to support improved contract and market engagement
  • Utilisation of standard national specification and Key Performance Indicators
  • Wide choice of awarded supplier and service level to suit local requirements

Start date


End date


Contract type

Framework Agreement

Framework owner

East of England NHS Collaborative Procurement Hub


ABI 0 - 3% ABI is applicable to service charges payable by the hospital to the homecare provider. These include charges for dispense & delivery, nursing services, compounding and equipment rental. ABI is not applied to the significant drugs spend reported via the Management Information data.

Award type

Direct award
Further competition

List of suppliers and awarded lots

Alcura Uk Limited, Calea UK Limited, Healthcare at Home ltd, Lloyds Pharmacy Clinical Homecare, Pharmaxo Pharmacy Services Ltd, Polar Speed Distribution Limited.

Contact name

Joe Bassett

Contact email

Contact number